首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Pathology >Clinicopathologic significance and treatment of ASC-US in cervical cytology
【2h】

Clinicopathologic significance and treatment of ASC-US in cervical cytology

机译:ASC-US在宫颈细胞学中的临床病理意义及治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: In China, cervical cancer is one of the most common gynecologic malignancies. Cervical cytology is an essential method for screening cervical cancer and cervical intraepithelial neoplasia (CIN), and the most common cytological abnormality result is atypical squamous cells of undetermined significance (ASC-US). Therefore, how to effectively deal with ASC-US cytology has become the focus of scholars. Objective: We aim to analyze the final histopathologic results, clinicopathologic significance and current rationale of ASC-US cytology. Methods: All patients with first ASC-US cytological reports who attended our gynecological outpatient clinic in Qilu Hospital of Shandong University during January 2010 to December 2015 were recruited to this study. The data were derived from clinical records and evaluated retrospectively. The results of age, High-Risk HPV (DNA) testing, colposcopy, and pathological outcomes were obtained. Directed biopsy was performed if there were any suspicious cervical lesions under colposcopy, while four quadrant biopsy and/or ECC were performed if no suspicious lesions were noted in colposcopies. Results: A total of 1246 patients diagnosed with ASC-US were involved in the final statistical analysis. Mean age of patients was 41.6 years and the age range between 40-49 years represented 38.52% of all ASC-US women in this study. All patients were evaluated for HPV (DNA) and positive percent for High-Risk HPV was (67.1%). According to the final histopathologic outcomes after ASC-US cytology, 15.6% and 1.1% of patients had ≥ CIN2+ and invasive carcinoma respectively. Patients with invasive carcinoma were associated with HPV16+ and HPV18+. The detection rate of ≥ CIN2+ among the ASC-US/High-Risk HPV+ group was (53.9%) with a negative-predictive-value (NPV) of 100%. Our findings showed that the final pathologic results of ≥ CIN2+ were consistent with colposcopy with a coincidence rate of (77%), and colposcopical impression sensitivity and specificity for ≥ CIN2+ was (91.1% and 96.1%) respectively. Conclusion: women with ASC-US have a wide range of final pathologic results, and it can be the initial warning of high-grade CIN or cervical cancer. In China, HPV (DNA) testing triage is a useful shunting measure for ASC-US patients, and an immediate colposcopy is a consequential strategy for dealing with ASC-US cytology to increase the detection rate of high-grade cervical lesions or invasive cancer.
机译:背景:在中国,宫颈癌是最常见的妇科恶性肿瘤之一。宫颈细胞学检查是筛查宫颈癌和宫颈上皮内瘤样病变(CIN)的必不可少的方法,最常见的细胞学异常结果是意义不明的非典型鳞状细胞(ASC-US)。因此,如何有效处理ASC-US细胞学已成为学者关注的焦点。目的:我们旨在分析ASC-US细胞学的最终组织病理学结果,临床病理学意义和当前原理。方法:选择2010年1月至2015年12月在山东大学齐鲁医院妇科门诊就诊的所有首次ASC-US细胞学报告的患者。数据来自临床记录,并进行回顾性评估。获得了年龄,高危HPV(DNA)测试,阴道镜检查和病理结果的结果。如果在阴道镜检查下发现可疑宫颈病变,则进行定向活检;如果在阴道镜检查中未发现可疑病变,则进行四象限活检和/或ECC。结果:总共1246名被诊断为ASC-US的患者参与了最终的统计分析。患者平均年龄为41.6岁,年龄在40-49岁之间,占本研究中所有ASC-US女性的38.52%。对所有患者的HPV(DNA)进行了评估,高危HPV的阳性百分比为(67.1%)。根据ASC-US细胞学检查后的最终组织病理学结果,分别有≥CIN2 +和浸润性癌的患者占15.6%和1.1%。浸润性癌患者与HPV16 +和HPV18 +相关。 ASC-US /高危HPV +组中CIN2 +≥的检出率为(53.9%),阴性预测值(NPV)为100%。我们的研究结果表明,≥CIN2 +的最终病理结果与阴道镜检查一致,符合率为(77%),并且阴道镜对≥CIN2 +的印象敏感性和特异性分别为(91.1%和96.1%)。结论:患有ASC-US的女性具有广泛的最终病理结果,这可能是高级别CIN或宫颈癌的初步警告。在中国,HPV(DNA)分流检查是ASC-US患者的一种有用的分流措施,而即时阴道镜检查是处理ASC-US细胞学以提高高级别宫颈病变或浸润性癌的检出率的一种相应策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号